TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
CCL3+ Neutrophil Signature Predicts Response to Neoadjuvant Toripalimab plus Chemotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Phase II Trial.
Fang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.